Brain Mechanisms of Overeating in Children (RO1)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03341247 |
Recruitment Status :
Enrolling by invitation
First Posted : November 14, 2017
Last Update Posted : April 1, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Pediatric Obesity Inhibition Decision Making fMRI |
In aim one, the investigators will use functional magnetic resonance imaging to characterize the brain regions which are activated in response to food portion size and compare these regions between high- and low-risk children.
Second, the investigators will determine the relationship between brain response to visual portion size cues and measured food intake when portions are increased in the laboratory.
Third, the investigators will determine the relationship between brain response to large portions and other validated measures of overeating, including satiety responsiveness and the amount of calories children consumed from high calorie snacks when they are not hungry (i.e., eating in the absence of hunger).
Fourth, the investigators will conduct follow-up visits one year after baseline to determine the extent to which baseline brain and behavioral responses to portion size predict gains in adiposity assessed by anthropometrics (body weight, height, and dual-energy x-ray absorptiometry).
Secondary study endpoints include the relationship between child behavioral and brain response to food portion size and physical activity assessed by accelerometry and questionnaires, inhibitory control assessed by a stop signal test, reward-related design making assessed by a computer task, working memory assessed by an N-back task loss of control eating, child sleep, child working memory, child meal microstructure assessed by observational meal coding, parent rated eating behaviors, and parental feeding practices.
Study Type : | Observational |
Estimated Enrollment : | 240 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Official Title: | Brain Mechanisms of Overeating in Children |
Actual Study Start Date : | January 31, 2018 |
Estimated Primary Completion Date : | December 31, 2023 |
Estimated Study Completion Date : | December 31, 2023 |
Group/Cohort |
---|
Low-risk of obesity
Children whose biological mother and biological father have a body mass index between 18.5 - 25 kg/m2.
|
High-risk of obesity
Children whose biological mother has a body mass index greater than or equal to 30 kg/m2 and whose biological father have a body mass index greater than or equal to 25 kg/m2.
|
- Brain Responses to Portion Size [ Time Frame: baseline ]The investigators will use functional magnetic resonance imaging to characterize the brain regions which are activated in response to food portion size and compare these regions between high- and low-risk children.
- Food Intake Relationship to Portion Size [ Time Frame: baseline ]The investigators will determine the relationship between brain response to visual portion size cues and measured food intake when portions are increased in laboratory meals.
- The Change in DXA analysis of child adiposity after 1 year [ Time Frame: From baseline visit to 1 year later ]The investigators will determine the extent to which baseline brain and behavioral responses to portion size predict gains in adiposity assessed by anthropometrics (body weight, height, and dual-energy x-ray absorptiometry). Body weight (kg) and Height (m) will be aggregated to report BMI in kg/m^2.
- Brain Response Relationships [ Time Frame: baseline ]The investigators will determine the relationship between brain response to large portions and other validated measures of overeating, including satiety responsiveness and the amount of calories children consumed from high calorie snacks when they are not hungry (i.e., eating in the absence of hunger).
- Inhibitory control assessed by a Stop Signal test [ Time Frame: baseline ]An additional endpoint includes the relationship between child behavioral and brain response to food portion size and Inhibitory control assessed by a Stop Signal test.
- Reward-related design [ Time Frame: baseline and 1 year later ]Reward-related design making assessed by a computer task.
- Working memory [ Time Frame: baseline and 1 year later ]Working memory assessed by an N-back task.
- Meal microstructure [ Time Frame: baseline and 1 year later ]Meal microstructure assessed by observational meal coding.
- Eating in the absence of hunger [ Time Frame: baseline and 1 year later ]Assessing child eating in the absence of hunger by buffet meal intake.
- Physical Activity [ Time Frame: baseline ]An additional endpoint include the relationship between child behavioral and brain response to food portion size and physical activity assessed by accelerometry.
- Loss of control eating [ Time Frame: baseline ]An additional endpoint include the relationship between child behavioral and brain response to food portion size and Loss of control eating.
- Parent-described eating behaviors [ Time Frame: baseline ]An additional endpoint includes the relationship between child behavioral and brain response to food portion size and Parent-described eating behaviors.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 7 Years to 8 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Child is in good health based on parental self-report
- Child has no learning disabilities (e.g., ADHD)
- Child has no diagnosed psychological or medical conditions/devices, or metal in/on the body that may impact comfort or safety in the fMRI (e.g., anxiety, insulin pump)
- Child is not on any medications known to influence body weight, taste, food intake, behavior, or blood flow
- Child is not claustrophobic
- Child is between the ages of 7-8 years-old at enrollment
- Child's immediate family members have not been diagnosed with a psychological disorder, including depression, anxiety, schizophrenia, etc.
- Child's biological mother and biological father have a body mass index either between 18.5 - 25 kg/m2 (low-risk group) or biological mother has a body mass index greater than or equal to 30 kg/m2 and biological father has a body mass index greater than or equal to 25 kg/m2 (high-risk group)
- Child's parent participating in study must be available to attend visits with child
Exclusion Criteria:
- Child is not in good health based on parent self-report
- Child has any learning disabilities (e.g., ADHD)
- Child has any psychological or medical conditions/devices that may impact comfort in the fMRI (e.g., anxiety, insulin pump)
- Child is taking any medications known to influence body weight, taste, food intake, behavior, or blood flow
- Child is claustrophobic
- Child is less than 7 or greater than 8 years-old at enrollment
- Child has any immediate family members diagnosed with a psychological disorder, including depression, anxiety, schizophrenia, etc.
- Child's biological mother or biological father's body mass index do not fit into the parameters for either group (both biological parents < 18.5 for low-risk group or biological mother is < 30 and biological father is < 25 for high-risk group)
- Child's parent participating in study is not available to attend visits with child
- Child is blue/green colorblind
- Child is not fluent in the English language

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03341247
United States, Pennsylvania | |
The Pennsylvania State University | |
University Park, Pennsylvania, United States, 16802 |
Principal Investigator: | Kathleen L Keller, Ph.D. | Penn State University |
Publications:
Responsible Party: | Kathleen Loralee Keller, Director, Penn State University |
ClinicalTrials.gov Identifier: | NCT03341247 |
Other Study ID Numbers: |
RO1 Study |
First Posted: | November 14, 2017 Key Record Dates |
Last Update Posted: | April 1, 2022 |
Last Verified: | March 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | De-identified data will be shared with other investigators by special request made by email to the PI (Kathleen L. Keller klk37@psu.edu). For investigators who request use of the data, we will request acknowledgement of our research group and Penn State University in any public presentation of the results obtained from this study. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Obesity Portion Size Effect fMRI Functional Magnetic Resonance Imaging Inhibition Decision Making |
Satiety Responsiveness Anthropometrics DXA Reward Processing Working Memory Meal microstructure |
Pediatric Obesity Hyperphagia Obesity Overnutrition |
Nutrition Disorders Overweight Body Weight Signs and Symptoms, Digestive |